MedPath

Wear rate of a Highly Cross-Linked polyethylene stabilized with vitamin E in Total Hip Arthroplasty.;A Randomized Controlled Trial

Withdrawn
Conditions
coxarthosis
hip arthrosis
10023213
10005944
Registration Number
NL-OMON34827
Lead Sponsor
Diakonessenhuis Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

All patients scheduled for a total hip arthroplasty. Inclusion criterion, patients diagnosed for coxarthrosis, dysplastic coxarthrosis, rheumatoid arthritis , necrosis of the head of the femur or posttraumatic coxarthrosis. Patients between 20 and 75 years old at the time of inclusion.

Exclusion Criteria

Exclusion criteria; patients designated for revision surgery, suffer from sepsis, malignant tumours, severe diabetes mellitus, severe cardiovascular diseases (ASA>II)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary final study point is the polyethylene wear rates. Measuring is<br /><br>based on anterior-posterior (AP) radiographs at 3,12 and 24 months using a<br /><br>computer-assisted edge-detection system (ROGAN Delft, VPX ortho)<br /><br>The software calculates femoral head displacement (mm) and the angle (°) as a<br /><br>representation of wear. </p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath